« Volver a Noticias

AASLD,The Liver Meeting(TLM), Open Submissions for Abstracts

For 74 years, The Liver Meeting® (TLM) has remained the world’s premier event for hepatology professionals. Organized by the American Association for the Study of Liver Diseases (AASLD), this event brings together physicians, scientists, and allied healthcare professionals from around the world to learn, innovate, and overcome challenges in the field of liver health.

This year, TLM 2023 will take place from November 10-14 in Boston, MA, as well as online, and the AASLD is inviting the best and brightest minds in hepatology to join leading experts in sharing cutting-edge research, clinical best practices, and collaborative solutions.

In addition to the many learning opportunities, TLM 2023 will also provide a platform for attendees to network with peers, connect with potential collaborators, and forge new partnerships that can help advance their work and impact patient outcomes.

One of the key highlights of TLM 2023 will be the presentation of abstracts, which are open for submission from March 23 at 8:00 a.m. (Eastern Time) through May 24. The submission site will close on May 24, 2023, at 11:59 p.m. (Eastern Time). This is a unique opportunity for professionals to showcase their research and contribute to the collective knowledge of the field.

By participating in TLM 2023, attendees will not only advance their own knowledge and skills but also contribute to the advancement of the field of liver health as a whole. The AASLD’s commitment to bringing professionals together to innovate, learn, and overcome challenges has made TLM the premier event in hepatology for more than seven decades, and this year’s event promises to be no exception.

In conclusion, if you are a hepatology professional looking to connect with peers, learn from leading experts, and contribute to the advancement of the field, TLM 2023 is the event for you. Don’t miss your chance to participate in this premier event and submit your abstract today. Together, we can continue to strengthen the hepatology community and improve patient outcomes around the world.